ClinicalTrials.Veeva

Menu

Indocyanine Green Fluorescence During Fundus First Laparoscopic Cholecystectomy (INFUNDUS)

Karolinska Institute logo

Karolinska Institute

Status

Begins enrollment in 2 months

Conditions

Gallstone
Gallstone; Cholecystitis, Acute

Treatments

Procedure: Indocyanine Green
Procedure: Cholangiography

Study type

Interventional

Funder types

Other

Identifiers

NCT06918210
INFUNDUS

Details and patient eligibility

About

Laparoscopic cholecystectomy is the routine method for managing gallstone disease. This is considered a safe procedure with low risk of severe complications. Lesions to the deep bile ducts is, however, a rare complication from laparoscopic cholecystectomy that may have devastating consequences. The risk of bile duct injuries may be reduced by adapting the surgical approach. In general, the operation is started from the lower part of the gallbladder and continued upwards. It may, however, also be initiated from the top of the gallbladder and extended downwards. This approach, also termed fundus first, is routine at a few units.

By injecting Indocyanin Green (ICG) that is excreted into the bile, the bile ducts may be visualized using near infrared light. This is a technique for mapping the anatomical structures adjacent to the gallbladder that has been used in previous studies for preventing bile duct injuries. This method has, however, not been tested at units where fundus first is the routine surgical technique. In the present randomized controlled trial, the investigators intend to evaluate the safety of ICG as a means for reducing the risk of bile duct lesions and to see if it works as intended.

Altogether 294 operations for gallstones will be included in the study. The patients will be randomized to surgery with or without ICG. Regardless of the randomization, all operations will be undertaken with the fundus first technique.

Thirty days after the operation, all data related to the operation are retrieved from the patient records by an assessor that does not know what group the patient was randomized to. The primary endpoint of the study is the time required from the start of the operation until intraoperative cholangiography is done. In addition, total operative time, all surgical complications and need for converting the operation to an open procedure will be recorded.

Enrollment

294 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients undergoing laparoscopic cholecystectomy
  • Verbal and written consent provided
  • Age ≥ 18 years

Exclusion criteria

  • Thyroid disease
  • Allergy against ICG or Iodine

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

294 participants in 2 patient groups

Visualization with ICG
Experimental group
Description:
Intraoperative visualization of the bile ducts with ICG and near infrared light
Treatment:
Procedure: Cholangiography
Procedure: Indocyanine Green
Comparator
Active Comparator group
Description:
Visualization of the bile ducts with intraoperative cholangiography only.
Treatment:
Procedure: Cholangiography

Trial contacts and locations

0

Loading...

Central trial contact

Susanna Haverinen, MD; Gabriel Sandblom, Associate Professor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems